An Innovative Ultrasound Technique for Early Detection of Kidney Dysfunction: Superb Microvascular Imaging as a...

Area of Science:

• Nephrology
• Medical Imaging
• Ultrasound Technology

Background:

• Superb microvascular imaging (SMI) offers enhanced visualization of small vessels.
• SMI's potential in assessing chronic kidney disease (CKD) severity and histological changes is explored.
• The study hypothesizes SMI's utility in reflecting CKD progression.

Purpose of the Study:

• To evaluate Superb Microvascular Imaging (SMI) for early detection of kidney dysfunction and renal fibrosis.
• To compare SMI capabilities against the gold standard of renal biopsy for diagnosing kidney fibrosis.
• To assess SMI's effectiveness in early diagnosis of kidney fibrosis.

Main Methods:

• Superb Microvascular Imaging (SMI) was performed on 52 patients with CKD stages 2-5 and 17 healthy controls.
• Biochemical tests included kidney function tests, proteinuria assessment, and estimated glomerular filtration rate (eGFR).
• Vascularity was quantified using the SMI index, where lower values indicate reduced vascularity and increased fibrosis.

Main Results:

• CKD patients exhibited a significantly lower SMI index compared to healthy controls (49.9 ± 16.7% vs. 72.2 ± 12.9%, p < 0.01).
• A moderate correlation was observed between the SMI index and eGFR (r = 0.56, p < 0.001) in CKD patients.
• The SMI index strongly correlated with serum creatinine (SCr) (r = -0.54, p < 0.001) and aligned with histological findings in biopsy-proven cases.

Conclusions:

• Superb Microvascular Imaging (SMI) shows promise for evaluating chronic renal morphological changes in CKD patients.
• SMI can differentiate between various grades of chronic kidney disease.
• This technique may serve as a valuable tool for non-invasive assessment of CKD severity.